What is the research dosage pattern of epitalon?

The literature describes epitalon in short, discrete courses — a modest daily amount over a run of days to a few weeks, then a break, repeated as separate courses rather than run continuously. Because each dose is small and short-lived, the course structure is the meaningful unit. These figures are reproduced strictly as a laboratory research reference and are not a human dosing protocol or medical advice.

Why is epitalon dosed in courses instead of continuously?

Because at only four residues it clears the bloodstream within minutes and is not a depot molecule. The research interest is the cumulative effect of a repeated course rather than a sustained circulating level, so the protocol pattern is days-on-then-break rather than an open-ended daily schedule.

What should an epitalon COA confirm?

The exact Ala-Glu-Asp-Gly (AEDG) sequence by mass spectrometry. A four-residue acidic peptide is small enough that a wrong-sequence or partially-deleted impostor sits close in mass and a bare HPLC purity number can't distinguish it — so identity by MS comes first, purity percentage second.

Does Titan sell epitalon?

No. Titan does not stock epitalon. This page is an informational dosing reference and an honest pointer to Titan's in-house-tested research peptides. Nothing here claims an anti-aging or longevity outcome — epitalon's human evidence base is limited and largely from a single research group.

Is epitalon injected or used intranasally?

The research literature reports both routes — subcutaneous injection and an intranasal preparation. As with any research compound the route affects exposure, and the figures here are a laboratory reference for in-vitro and modelling work, not a human-use instruction.

Epitalon · epithalon · AEDG tetrapeptide · research use only

Epitalon is a four-residue peptide dosed in short courses, not on a daily forever schedule.

Epitalon — also written epithalon or epithalone — is one of the smallest peptides in this whole catalog conversation: the tetrapeptide Ala-Glu-Asp-Gly (AEDG), synthesised from the amino-acid composition of the pineal extract epithalamin. Its dosing pattern is distinctive: the research literature describes it in short defined courses — a small daily amount over a period of days to a few weeks, repeated as discrete courses rather than run continuously. This page reproduces that course-based pattern as a laboratory reference, explains why a tiny acidic tetrapeptide clears the bloodstream almost immediately, and covers the identity check a four-residue peptide specifically needs. Framed as a research reference, not a human protocol. Titan does not stock epitalon; see the honest catalog pointer below.

Where to buy epitalon — sourcing & COA In-house-tested research peptides

Dosed as short courses

The defining feature of epitalon in the literature is that it is administered in short, discrete courses — a modest daily amount over a run of days to a few weeks, then a break, rather than an open-ended daily schedule. The original work by Khavinson and colleagues framed it this way. Reproduced here strictly as a laboratory research reference for in-vitro and modelling work, not a human instruction.

Sourcing and COA notes →

Clears almost immediately

At only four residues, epitalon is not a depot molecule — a small linear peptide of this size is cleared from the bloodstream within minutes. That is precisely why the research pattern is a repeated course rather than a single sustained dose: the compound is present briefly and the protocol interest is the cumulative effect of a course, not a long circulating half-life. A researcher modelling it is modelling brief, repeated exposure.

Reference framing →

Reconstitution math

Epitalon ships lyophilized and the working concentration is set by the diluent volume. As a worked example, a 10 mg vial in 2 mL of bacteriostatic water yields 5 mg/mL, so 0.2 mL on a U-100 insulin syringe draws 1 mg. Because the per-course amounts are small, dilution errors matter proportionally more — confirm your vial's stated mass and run the numbers before any in-vitro modelling rather than assuming a concentration.

Run the numbers →

The tiny-peptide identity check

A four-residue acidic peptide (Ala-Glu-Asp-Gly) is small enough that a wrong-sequence or partially-deleted impostor sits very close in mass, and a bare HPLC 'purity' number cannot tell one short acidic tetrapeptide from another. A meaningful certificate confirms the exact AEDG sequence by mass spectrometry — identity first, purity second. This is the verification point specific to a peptide this small.

The epitalon COA angle →

Why 'course' matters more than a single number

For most compounds a single dose figure tells most of the story. For epitalon, the course structure — how many days on, the total across the course, and how courses are spaced — is the variable that actually defines a protocol, precisely because each individual dose is small and short-lived. Treat the course, not one milligram figure, as the unit of comparison.

Research-use context →

Research-use framing

These figures describe patterns used in epitalon research, reproduced strictly as a laboratory reference for in-vitro and modelling work — not instructions for human use. Epitalon's human evidence base is limited and largely from a single research group; Titan does not sell it and supplies only research-use-only reagents, not for human or animal consumption. Nothing here is medical or dosing advice, and no anti-aging or longevity outcome is claimed.

Research-use policy →

The detail, in plain terms

The epitalon reference, in one table.

Epitalon's dosing is defined by its course structure and its tiny size, not by a single sustained figure. These are the variables a researcher weighs when modelling it — reproduced as a reference, not a human protocol. Titan does not stock epitalon.

Compound: Epitalon (epithalon / AEDG) — the tetrapeptide Ala-Glu-Asp-Gly.
Research pattern: Short discrete courses — a small daily amount over days to a few weeks, repeated.
Route: Reported both as subcutaneous injection and as an intranasal preparation.
Clearance: Very short — a 4-residue linear peptide clears within minutes, hence the course design.
Reconstitution: 10 mg vial + 2 mL BAC water → 5 mg/mL (0.2 mL ≈ 1 mg).
COA focus: Confirm the exact AEDG sequence by MS — a purity % can't tell short acidic peptides apart.
Titan catalog: Not stocked. Honest pointer: Titan's in-house-tested research peptides.

Questions researchers ask

Before you order.

What is the research dosage pattern of epitalon?: The literature describes epitalon in short, discrete courses — a modest daily amount over a run of days to a few weeks, then a break, repeated as separate courses rather than run continuously. Because each dose is small and short-lived, the course structure is the meaningful unit. These figures are reproduced strictly as a laboratory research reference and are not a human dosing protocol or medical advice.
Why is epitalon dosed in courses instead of continuously?: Because at only four residues it clears the bloodstream within minutes and is not a depot molecule. The research interest is the cumulative effect of a repeated course rather than a sustained circulating level, so the protocol pattern is days-on-then-break rather than an open-ended daily schedule.
What should an epitalon COA confirm?: The exact Ala-Glu-Asp-Gly (AEDG) sequence by mass spectrometry. A four-residue acidic peptide is small enough that a wrong-sequence or partially-deleted impostor sits close in mass and a bare HPLC purity number can't distinguish it — so identity by MS comes first, purity percentage second.
Does Titan sell epitalon?: No. Titan does not stock epitalon. This page is an informational dosing reference and an honest pointer to Titan's in-house-tested research peptides. Nothing here claims an anti-aging or longevity outcome — epitalon's human evidence base is limited and largely from a single research group.
Is epitalon injected or used intranasally?: The research literature reports both routes — subcutaneous injection and an intranasal preparation. As with any research compound the route affects exposure, and the figures here are a laboratory reference for in-vitro and modelling work, not a human-use instruction.